S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.115.302072PMID 26515415PMCID PMC4771489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular smooth muscle cell calcification is mediated by regulated exosome secretion.

  2015cited by this paper
• Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease.

  2015cited by this paper
• EN-RAGE: A Novel Inflammatory Marker for Incident Coronary Heart Disease

  2014cited by this paper
• Serum S100A12 concentrations are correlated with angiographic coronary lesion complexity in patients with coronary artery disease

  2014cited by this paper
• S100/Calgranulin-Mediated Inflammation Accelerates Left Ventricular Hypertrophy and Aortic Valve Sclerosis in Chronic Kidney Disease in a Receptor for Advanced Glycation End Products–Dependent Manner

  2014cited by this paper
• Abstract 19298: Is the Seasonal Variation in Acute Aortic Dissection Occurrence Associated with Flu Activity?

  2014cited by this paper
• A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

  2014cited by this paper
• RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice

  2014influential reference
• Intensive Cardiovascular Risk Reduction Induces Sustainable Changes in Expression of Genes and Pathways Important to Vascular Function

  2014cited by this paper
• A new protective role for S100A9 in regulation of neutrophil recruitment during invasive pneumococcal pneumonia

  2014cited by this paper
• The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation

  2013cited by this paper
• Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.

  2013cited by this paper
• Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.

  2013cited by this paper
• S100A12 Gene Expression Is Increased in Peripheral Leukocytes in Chronic Kidney Disease Stage 4-5 Patients with Cardiovascular Disease

  2013cited by this paper
• Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice.

  2013influential reference
• The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth

  2013cited by this paper
• Serum S100A12 Levels Are Correlated With the Presence and Severity of Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus

  2013cited by this paper
• Role of Extracellular Vesicles in De Novo Mineralization: An Additional Novel Mechanism of Cardiovascular Calcification

  2013cited by this paper
• Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.

  2013influential reference
• Low-dose colchicine for secondary prevention of cardiovascular disease.

  2013cited by this paper
• S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications.

  2012influential reference
• Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification

  2012cited by this paper
• Inflammation in Atherosclerosis

  2012cited by this paper
• Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus.

  2012cited by this paper
• Placebo-controlled trial of oral laquinimod for multiple sclerosis.

  2012cited by this paper
• Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized controlled trial.

  2012cited by this paper
• Functions of S100 proteins.

  2012cited by this paper
• Myocardial infarction accelerates atherosclerosis

  2012influential reference
• Genetic pathways of vascular calcification.

  2012cited by this paper
• S100A12 as a marker to predict cardiovascular events in patients with chronic coronary artery disease.

  2012cited by this paper
• Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling

  2012cited by this paper
• Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.

  2012cited by this paper
• S100A8 and S100A9 in cardiovascular biology and disease.

  2012cited by this paper
• Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients.

  2011cited by this paper
• Interleukin 18 and coronary heart disease: Prospective study and systematic review

  2011cited by this paper
• Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.

  2011cited by this paper
• Vascular Remodeling and Arterial Calcification Are Directly Mediated by S100A12 (EN-RAGE) in Chronic Kidney Disease

  2011influential reference
• Increased Levels of Calprotectin in Obesity Are Related to Macrophage Content: Impact on Inflammation and Effect of Weight Loss

  2011cited by this paper
• S100/calgranulins EN-RAGEing the blood vessels: implications for inflammatory responses and atherosclerosis.

  2011cited by this paper
• Plasma S100A12 Levels and Peripheral Arterial Disease in End-Stage Renal Disease

  2011cited by this paper
• Matrix vesicles isolated from mineralization-competent Saos-2 cells are selectively enriched with annexins and S100 proteins.

  2011cited by this paper
• Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).

  2011cited by this paper
• S100A12 in Vascular Smooth Muscle Accelerates Vascular Calcification in Apolipoprotein E–Null Mice by Activating an Osteogenic Gene Regulatory Program

  2011cited by this paper
• Carboxylated N‐glycans on RAGE promote S100A12 binding and signaling

  2010influential reference
• Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients

  2010cited by this paper
• S100A12 Mediates Aortic Wall Remodeling and Aortic Aneurysm

  2010cited by this paper
• The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

  2010cited by this paper
• Pathophysiology of vascular calcification: Pivotal role of cellular senescence in vascular smooth muscle cells.

  2010cited by this paper
• Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.

  2010cited by this paper
• Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans

  2009cited by this paper
• Toll-like receptors and cancer

  2009cited by this paper
• The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.

  2009cited by this paper
• Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury

  2009cited by this paper
• Oxidative modifications of S100 proteins: functional regulation by redox

  2009cited by this paper
• G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects.

  2009cited by this paper
• Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture1

  2009cited by this paper
• Leptin and coronary heart disease: prospective study and systematic review.

  2009cited by this paper
• Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides

  2009cited by this paper
• Calprotectin — A Novel Marker of Obesity

  2009cited by this paper
• Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.

  2008influential reference
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Mast Cell and Monocyte Recruitment by S100A12 and Its Hinge Domain*

  2008influential reference
• Increased Plasma S100A12 (EN-RAGE) Levels in Hemodialysis Patients with Atherosclerosis

  2008cited by this paper
• Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT Signaling*

  2008cited by this paper
• Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial.

  2008cited by this paper
• Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis

  2008cited by this paper
• Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

  2007cited by this paper
• Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro

  2007cited by this paper
• S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity.

  2007cited by this paper
• Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.

  2006cited by this paper
• Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events

  2006cited by this paper
• Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.

  2004cited by this paper
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

  2004cited by this paper
• The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus.

  2004cited by this paper
• Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics: A Postmortem Study

  2004cited by this paper
• Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

  2004cited by this paper
• Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity.

  2003cited by this paper
• Central role of RAGE-dependent neointimal expansion in arterial restenosis.

  2003cited by this paper
• Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis.

  2003cited by this paper
• The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis.

  2002cited by this paper
• RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

  2002influential reference
• Genomic scan for genes affecting body composition before and after training in Caucasians from HERITAGE.

  2001cited by this paper
• Linomide in relapsing and secondary progressive MS

  2000cited by this paper
• Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

  2000cited by this paper
• Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials

  2000influential reference
• Linomide in relapsing and secondary progressive MS

  2000cited by this paper
• S100A12 Is Expressed Exclusively by Granulocytes and Acts Independently from MRP8 and MRP14*

  1999cited by this paper
• RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

  1999cited by this paper
• Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family.

  1999cited by this paper
• Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

  1998cited by this paper
• Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

  1993cited by this paper
• Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

  1992cited by this paper
• Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice

  1989influential reference
• Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice.

  1986cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(11):5423–5428 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032223

  year unknowncited by this paper

• Elevated acute-phase plasma levels of S100A12 [EN-RAGE] are associated with vascular recurrence after ischemic stroke.

  2026cites this paper
• S100A12 drives inflammatory and metabolic reprogramming in sepsis-associated acute kidney injury

  2026cites this paper
• Transcriptomic insights into the co-occurring psychological symptoms and cardiovascular risks among military service members and veterans with mild traumatic brain injury: A LIMBIC-CENC study

  2026cites this paper
• S100 proteins as a key immunoregulatory mechanism for NLRP3 inflammasome

  2025cites this paper
• Advanced glycation end-product receptor gene (RAGE) polymorphisms in patients with acute coronary syndrome – a case-control study in the Polish population

  2025cites this paper
• Association of Copper with Atherosclerosis and Treatment Strategies

  2025cites this paper
• Neutrophil-mediated effects of S100A12 on major adverse cardiovascular events: Insights from the UK biobank

  2025cites this paper
• Novel cardiac biomarkers (Serum S100A12 (Calgranulin C), FSTL1 (Follistatin-like 1), and Osteocalcin) in patients with Acute Chest Pain

  2025cites this paper
• Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy

  2025cites this paper
• The roles of S100A8/A9 and S100A12 in autoimmune diseases: Mechanisms, biomarkers, and therapeutic potential.

  2025cites this paper
• Serum S100A12 in the clinical diagnosis of sepsis-induced myocardial dysfunction: an integrated bioinformatics and clinical data analysis

  2025cites this paper
• Identification of Neutrophil Extracellular Trap-Related Biomarkers in Diabetic Foot Ulcers Based on Bioinformatics

  2025cites this paper
• Modulation of Aging Diseases via RAGE Targets: A Dietary Intervention Review

  2025cites this paper
• Bioinformatics gene analysis of potential biomarkers associated with chronic kidney disease related ischemic stroke

  2025cites this paper
• Transcriptional responses in different mouse models of septic liver injury differ from those in patients with septic liver injury

  2025cites this paper
• Circulating protein biomarkers and their association with vulnerable plaque characteristics – a PROSPECT II substudy

  2025cites this paper
• Determining the biomarkers and pathogenesis of myocardial infarction combined with ankylosing spondylitis via a systems biology approach

  2025cites this paper
• Targeted proteomic biomarker profiling using NULISA in a cohort enriched with risk for Alzheimer's disease and related dementias

  2025cites this paper
• Association between S100A12 and risk of peripheral arterial disease in patients with dyslipidemia: a cross-sectional study

  2025cites this paper
• Advances in S100 protein family for gynecological malignancies

  2025cites this paper
• S100A12 triggers NETosis to aggravate myocardial infarction injury via the Annexin A5-calcium axis

  2025cites this paper
• The alarmin tandem: unraveling the complex effect of S100A8/A9 – from atherosclerosis to cardiac arrhythmias

  2025cites this paper
• The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population

  2024cites this paper
• Identification of S100A8/A9 involved in thromboangiitis obliterans development using tandem mass tags-labeled quantitative proteomics analysis.

  2024cites this paper
• Neutrophil extracellular traps: a catalyst for atherosclerosis

  2024cites this paper
• S100A12 is involved in the pathology of osteoarthritis by promoting M1 macrophage polarization via the NF-κB pathway

  2024cites this paper
• S100A4 Is a Key Facilitator of Thoracic Aortic Dissection

  2024cites this paper
• Targeted Proteomic Biomarker Profiling Using NULISA in a cohort enriched with risk for Alzheimer’s Disease and Related Dementias

  2024cites this paper
• Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic target

  2024cites this paper
• Amlexanox reduces new-onset atrial fibrillation risk in sepsis by downregulating S100A12: a Mendelian randomization study

  2024cites this paper
• Identification of core genes shared by ischemic stroke and myocardial infarction using an integrated approach

  2024cites this paper
• Targeting S100A12 to Improve Angiogenesis and Accelerate Diabetic Wound Healing

  2024cites this paper
• The Features of Shared Genes among Transcriptomes Probed in Atopic Dermatitis, Psoriasis, and Inflammatory Acne: S100A9 Selection as the Target Gene.

  2024cites this paper
• Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis

  2023cites this paper
• Linked Th17 and Calgranulin Responses in Maternal-cord Blood Dyads of Preterm Gestations with Histologic Chorioamnionitis

  2023cites this paper
• Identification of Potential Biomarkers for Coronary Artery Disease Based on Cuproptosis

  2023cites this paper
• Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease.

  2023cites this paper
• S-100 Proteins: Basics and Applications as Biomarkers in Animals with Special Focus on Calgranulins (S100A8, A9, and A12)

  2023cites this paper
• The functions and regulatory pathways of S100A8/A9 and its receptors in cancers

  2023cites this paper
• Circulating Profiles of Serum Proguanylin, S100A12 Protein and Pentraxin 3 as Diagnostic Markers of Ulcerative Colitis

  2023cites this paper
• Association of rs1800624 Polymorphism in Receptor for Advanced Glycation End Products Gene Promoter with the Risk of Diabetic Nephropathy

  2022cites this paper
• S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases

  2022cites this paper
• Increased serum S100A12 levels are associated with higher risk of acute heart failure in patients with type 2 diabetes

  2022cites this paper
• Polymorphisms of Calgranulin Genes and Ischemic Stroke in a Chinese Population

  2022cites this paper
• Multifunctional Role of S100 Protein Family in the Immune System: An Update

  2022cites this paper
• Neutrophil Infiltration Characterized by Upregulation of S100A8, S100A9, S100A12 and CXCR2 Is Associated With the Co-Occurrence of Crohn’s Disease and Peripheral Artery Disease

  2022influential citation
• Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial

  2022cites this paper
• Identification of hub genes and potential biomarkers of neutrophilic asthma: evidence from a bioinformatics analysis

  2022cites this paper
• LPS and oxLDL-induced S100A12 and RAGE expression in carotid arteries of atherosclerotic Yucatan microswine

  2022cites this paper
• Extracellular vesicle‐mediated endothelial apoptosis and EV‐associated proteins correlate with COVID‐19 disease severity

  2021cites this paper
• Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Attenuates Arterial Calcification By Downregulating Oxidative Stress-Induced Receptor for Advanced Glycation End Products in Low-Density Lipoprotein Receptor Knockout Mice

  2021cites this paper
• Clinical severity of serum S100A12 levels in patients with osteoarthritis and S100A12 open inflammation of osteoarthritis model by NLRP3

  2021cites this paper
• Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice

  2021cites this paper
• Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction

  2021cites this paper
• Identification of Transcriptomic Differences between Lower Extremities Arterial Disease, Abdominal Aortic Aneurysm and Chronic Venous Disease in Peripheral Blood Mononuclear Cells Specimens

  2021cites this paper
• Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia

  2021cites this paper
• Atorvastatin Reduces Circulating S100A12 Levels in Patients with Carotid Atherosclerotic Plaques - A Link with Plaque Inflammation

  2021cites this paper
• Discerning the promising binding sites of S100/calgranulins and their therapeutic potential in atherosclerosis

  2021cites this paper
• S100 family proteins in inflammation and beyond.

  2020cites this paper
• Molecular signatures of athersoclerotic plaques: An up-dated panel of protein related markers.

  2020cites this paper
• Value of S100A12 in predicting in-stent restenosis in patients with coronary drug-eluting stent implantation

  2020cites this paper
• Transcriptomes from German shepherd dogs reveal differences in immune activity between atopic dermatitis affected and control skin

  2020cites this paper
• An optical coherence tomography comparison of coronary arterial plaque calcification in patients with end-stage renal disease and diabetes mellitus

  2020cites this paper
• Mechanism of Long Non-Coding RNAs in Autophagy and Inflammation of Vascular Endothelial Cells: A Review

  2020cites this paper
• Immunological mechanisms underlying sterile inflammation in the pathogenesis of atherosclerosis: potential sites for intervention

  2020cites this paper
• Differential expression and role of S100 proteins in chronic rhinosinusitis.

  2020cites this paper
• Role of S100 proteins in health and disease.

  2020cites this paper
• Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Fluorine-18 labeling of S100 proteins for small animal positron emission tomography

  2020cites this paper
• Serum S100A12 levels are correlated with clinical severity in patients with dermatomyositis-associated interstitial lung disease

  2019cites this paper
• Utility of novel serum biomarkers to predict subclinical atherosclerosis: A sub-analysis of the EISNER study.

  2019cites this paper
• Fluorine-18 Labeling of S100 Proteins for Small Animal Positron Emission Tomography.

  2019cites this paper
• Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes

  2019cites this paper
• Ca(II) and Zn(II) Cooperate To Modulate the Structure and Self-Assembly of S100A12.

  2019cites this paper
• The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.

  2019cites this paper
• The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease

  2019cites this paper
• Damage-associated molecular patterns in trauma

  2019cites this paper
• S100 Proteins in Atherosclerosis.

  2019cites this paper
• Cardiovascular Disease in Systemic Lupus Erythematosus: recent data on epidemiology, risk factors and prevention.

  2019cites this paper
• The non-haemostatic role of platelets in systemic lupus erythematosus

  2018cites this paper
• The clinical value of serum S 100 B in patients with ST-segment elevation myocardial infarction

  2018cites this paper
• Universitet IL-18 and S 100 A 12 Are Upregulated in Experimental Central Retinal Vein Occlusion

  2018cites this paper
• Endogenous DAMPs, Category I: Constitutively Expressed, Native Molecules (Cat. I DAMPs)

  2018cites this paper
• Transcriptional analysis of differential immune responses to Sarcoptes scabiei infestation in a porcine model.

  2018cites this paper
• Aalborg Universitet IL-18 and S 100 A 12 Are Upregulated in Experimental Central Retinal Vein Occlusion

  2018cites this paper
• S100/RAGE-Mediated Inflammation and Modified Cholesterol Lipoproteins as Mediators of Osteoblastic Differentiation of Vascular Smooth Muscle Cells

  2018cites this paper
• IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion

  2018cites this paper
• Detection of Functional Overreaching in Endurance Athletes Using Proteomics

  2018cites this paper
• Glycemic reduction alters white blood cell counts and inflammatory gene expression in diabetes.

  2018cites this paper
• Damage-Associated Molecular Patterns in Inflammatory Diseases

  2018cites this paper
• Calgranulin C (S100A12) Is Differentially Expressed in Subtypes of Chronic Rhinosinusitis

  2018cites this paper
• Serum S100A12 and 30-day mortality after acute intracerebral hemorrhage.

  2018cites this paper
• S100 Proteins As an Important Regulator of Macrophage Inflammation

  2018influential citation
• Danger signals in trauma

  2018cites this paper
• Role of Ligands of Receptor for Advanced Glycation End Products (RAGE) in Peripheral Artery Disease

  2018cites this paper
• S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension

  2018cites this paper
• Effects of chemokine CCL2 on residual platelet activation in patients with STEMI

  2018cites this paper
• Studies on Cardiovascular Disease in Systemic Lupus Erythematosus

  2017cites this paper
• Salivary and Serum Markers Related to Innate Immunity in Generalized Aggressive Periodontitis

  2017cites this paper
• Correlation analysis of chemokine CX3CL1 level and the prognosis of ST elevation myocardial infarction

  2017cites this paper
• P2RX7 purinoceptor as a therapeutic target in Duchenne muscular dystrophy

  2017cites this paper